Drugs / PK101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04858659 | May 2021 → Mar 2022 | osteoarthritis, knee | PMG Pharm Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PK101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04858659 ↗ |